Leading Financial Service Provider in India | Canara Bank Securities Ltd

Vanta Bioscience Ltd.

Dec 31 BSE 23.50 (+ 0.90 3.98%)

Volume6000

Prev. Close
22.60

Open Price
20.60

Today's Low / High

20.60 23.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

16.85 44.30

Vanta Bioscience Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	16.71	P/BV	0.87	Book Value ( ₹ )	27.06
52 Week High/Low ( ₹ )	44/17	FV/ML	10/750	P/E(X)	0.00
Book Closure		EPS ( ₹ )	0.00	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	63.12	63.12	63.12	63.12	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31	6.31	6.31	6.31	6.31
Total Share Capital	6.31	6.31	6.31	6.31	6.31

Reserves and Surplus	4.11	8.89	11.20	17.70	17.61
Total Reserves and Surplus	4.11	8.89	11.20	17.70	17.61
Total Shareholders Funds	10.42	15.20	17.51	24.01	23.92
Minority Interest	-6.64	-2.23	1.41	5.34	2.31

NON-CURRENT LIABILITIES
Long Term Borrowings	54.13	48.80	47.07	37.00	27.84
Deferred Tax Liabilities [Net]	1.41	0.75	0.97	0.78	0.72
Total Non-Current Liabilities	55.53	49.55	48.03	37.78	28.56

CURRENT LIABILITIES
Short Term Borrowings	15.96	12.15	10.09	7.87	4.15
Trade Payables	4.94	5.57	4.22	2.46	0.47
Other Current Liabilities	5.66	5.16	3.43	3.91	10.16
Short Term Provisions	0.00	0.00	0.00	0.04	0.06
Total Current Liabilities	26.56	22.88	17.75	14.28	14.84

Total Capital And Liabilities	85.88	85.40	84.71	81.40	69.63

ASSETS
NON-CURRENT ASSETS
Tangible Assets	23.96	28.41	33.23	14.54	15.52
Intangible Assets	31.54	25.75	24.00	21.59	0.00
Capital Work-In-Progress	0.00	0.00	0.00	22.78	19.34
Intangible Assets Under Development	13.47	12.53	10.60	5.69	0.00
Other Assets	0.00	0.00	0.00	0.00	13.87
Fixed Assets	68.97	66.69	67.83	64.59	48.73
Other Non-Current Assets	1.56	1.55	1.64	2.32	0.97
Total Non-Current Assets	70.52	68.24	69.47	66.91	49.69


CURRENT ASSETS
Inventories	6.51	7.52	7.16	7.24	9.76
Trade Receivables	2.50	3.14	1.96	1.13	2.01
Cash And Cash Equivalents	0.22	0.16	0.10	0.22	2.65
Short Term Loans And Advances	5.63	5.77	5.38	5.18	4.87
OtherCurrentAssets	0.50	0.56	0.65	0.72	0.64
Total Current Assets	15.36	17.16	15.24	14.50	19.94

Total Assets	85.88	85.40	84.71	81.40	69.63

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31
Total Share Capital	6.31
Reserves and Surplus	4.11
Total Reserves and Surplus	4.11
Total Shareholders Funds	10.42
Minority Interest	-6.64
NON-CURRENT LIABILITIES
Long Term Borrowings	54.13
Deferred Tax Liabilities [Net]	1.41
Total Non-Current Liabilities	55.53
CURRENT LIABILITIES
Short Term Borrowings	15.96
Trade Payables	4.94
Other Current Liabilities	5.66
Short Term Provisions	0.00
Total Current Liabilities	26.56
Total Capital And Liabilities	85.88
ASSETS
NON-CURRENT ASSETS
Tangible Assets	23.96
Intangible Assets	31.54
Capital Work-In-Progress	0.00
Intangible Assets Under Development	13.47
Other Assets	0.00
Fixed Assets	68.97
Other Non-Current Assets	1.56
Total Non-Current Assets	70.52
CURRENT ASSETS
Inventories	6.51
Trade Receivables	2.50
Cash And Cash Equivalents	0.22
Short Term Loans And Advances	5.63
OtherCurrentAssets	0.50
Total Current Assets	15.36
Total Assets	85.88

Markets

Balance Sheet

BALANCE SHEET

Vanta Bioscience Ltd.